Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Health Canada Santé Canada STATUS DECISION OF CONTROLLED AND NON-CONTROLLED SUBSTANCE(S) Substance: Alter EgoTM Sex Attractant Based on the current information available to the Office of Controlled Substances, it appears that the above substance is: Controlled X Not Controlled ☐ under the schedules of the Controlled Drugs and Substances Act (CDSA) for the following reason(s): The product is claimed to contain androsterone and is therefore captured under item 23 of Schedule IV to the CDSA. Prepared by: _______________________________________ Evelyn C Soo Date: _______________ Verified by: Date: ________________ _______________________________________ Mark Kozlowski Approved by: _______________________________________ Date: ________________ DIRECTOR, OFFICE OF CONTROLLED SUBSTANCES This status was requested by: Viviane Luu, Inspectorate 2 Drug Status Report Drug: Alter EgoTM Sex Attractant Drug Name Status: Alter EgoTM Sex Attractant Concentrate is the product name. Canadian Status: Alter EgoTM Sex Attractant is marketed as a pheromone and is claimed to contain the following ingredients: Di-propylene glycol Essential oils SD40-B alcohol Fragrance Pure, Reagent-grade Human Pheromones (0.020% Androstenol, 0.015% Androsterone, 0.010%Androstenone) Dipropylene glycol is a widely used solvent and humectant that was previously reviewed and not included under the schedules to the CDSA. Essential oils containing more than 4% safrole are captured under item 17 of Part 1 of Schedule VI to the CDSA but there is no information on which essential oils are used as ingredients of this product. SD40-B alcohol is reportedly a denatured alcohol and is used to designate alcohol that is not suitable for consumption and is not structurally similar of those included in the CDSA. Copulins were previously reviewed and are volatile fatty acids with no structural similarity to any of the substances in the CDSA. Androstenol and androstenone were previously reviewed and were not included under item 23 “Anabolic steroids and their derivatives” of Schedule IV to the CDSA. However, the previous review of androsterone included the steroid under item 23 of Schedule IV to the CDSA. Given that this product contains androsterone, it must be included under item 23 of Schedule IV to the CDSA. Recommendation: Alter EgoTM Sex Attract is included under item 23 of Schedule IV to the CDSA and is a controlled substance. Date: Jan 2nd, 2013.